Devises / CRVS
CRVS: Corvus Pharmaceuticals Inc
5.74
USD
0.33
(6.10%)
Le taux de change de CRVS a changé de 6.10% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 5.34 et à un maximum de 5.75.
Suivez la dynamique Corvus Pharmaceuticals Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CRVS Nouvelles
- Core Scientific stock price target raised to $22 by Jefferies on acquisition outlook
- Corvus Stock: Positive Phase 1 Soquelitiinb Trial Data Brings 2025 Catalysts (NASDAQ:CRVS)
- Corvus Q1 2025 presentation: Phase 1 atopic dermatitis data drives stock surge
- Tuesday’s Insider Activity: Major Buys and Sells Shake Up Markets
- OrbiMed Advisors sells Corvus Pharma (CRVS) shares worth $4.89 million
- China approves Corvus partner’s IND for atopic dermatitis drug trial
- Corvus stock maintains Outperform rating at Mizuho amid positive sector data
- Corvus Pharmaceuticals: Multiple Opportunities, But Plenty Of Risk
- Corvus stock rating reiterated by Cantor Fitzgerald on atopic dermatitis drug
- Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
- Corvus reports promising interim data on atopic dermatitis drug
- Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
- Mizuho cuts Corvus Pharmaceuticals target to $11, keeps rating
- Why Is Corvus Pharmaceuticals Stock Soaring On Friday? - Corvus Pharma (NASDAQ:CRVS)
- Corvus Pharmaceuticals shares surge on positive trial results
- Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Corvus Pharma (NASDAQ:CRVS), Clean Energy Technologies (NASDAQ:CETY)
- Corvus Pharmaceuticals' Short Runway Overshadows Soquelitinib's Promising Trials
- Corvus Pharmaceuticals Stock: Now At Cruising Altitude (NASDAQ:CRVS)
- Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call Transcript
- Corvus Pharmaceuticals: Small Market, Many Competitors, Low Cash Balance (NASDAQ:CRVS)
Range quotidien
5.34
5.75
Range Annuel
2.54
10.01
- Clôture Précédente
- 5.41
- Ouverture
- 5.42
- Bid
- 5.74
- Ask
- 6.04
- Plus Bas
- 5.34
- Plus Haut
- 5.75
- Volume
- 1.039 K
- Changement quotidien
- 6.10%
- Changement Mensuel
- 40.00%
- Changement à 6 Mois
- 38.65%
- Changement Annuel
- 29.28%
31 août, dimanche